Synchrotron X-Ray Fluorescence Microscopy of Gallium in Bladder Tissue following Gallium Maltolate Administration during Urinary Tract Infection

被引:7
作者
Ball, Katherine R. [1 ]
Sampieri, Francesca [1 ]
Chirino, Manuel [2 ]
Hamilton, Don L. [1 ]
Blyth, Robert I. R. [3 ]
Sham, Tsun-Kong [4 ]
Dowling, Patricia M. [1 ]
Thompson, Julie [3 ]
机构
[1] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Biomed Sci, Saskatoon, SK S7N 0W0, Canada
[2] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK S7N 0W0, Canada
[3] Univ Saskatchewan, Canadian Light Source Inc, Saskatoon, SK, Canada
[4] Univ Western Ontario, Dept Chem, London, ON, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
UROPATHOGENIC ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; IRON-METABOLISM; ABSORPTION; MECHANISMS; PERSISTENCE; PREVALENCE; CATALYSTS; ELEMENTS; TRENDS;
D O I
10.1128/AAC.00616-13
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A mouse model of cystitis caused by uropathogenic Escherichia coli was used to study the distribution of gallium in bladder tissue following oral administration of gallium maltolate during urinary tract infection. The median concentration of gallium in homogenized bladder tissue from infected mice was 1.93 mu g/g after daily administration of gallium maltolate for 5 days. Synchrotron X-ray fluorescence imaging and X-ray absorption spectroscopy of bladder sections confirmed that gallium arrived at the transitional epithelium, a potential site of uropathogenic E. coli infection. Gallium and iron were similarly but not identically distributed in the tissues, suggesting that at least some distribution mechanisms are not common between the two elements. The results of this study indicate that gallium maltolate may be a suitable candidate for further development as a novel antimicrobial therapy for urinary tract infections caused by uropathogenic E. coli.
引用
收藏
页码:5197 / 5201
页数:5
相关论文
共 37 条
[1]  
Abramoff M.D., 2004, Biophotonics International, V11, P36
[2]  
Ball KR, 2008, CAN VET J, V49, P985
[3]  
Bernstein Lawrence R., 2000, Metal-Based Drugs, V7, P33, DOI 10.1155/MBD.2000.33
[4]  
Bernstein LR, 1998, PHARMACOL REV, V50, P665
[5]   ROLE OF LYSOSOMES IN GALLIUM CONCENTRATION BY MAMMALIAN-TISSUES [J].
BERRY, JP ;
POUPON, MF ;
GALLE, S ;
ESCAIG, F .
BIOLOGY OF THE CELL, 1984, 51 (01) :43-51
[6]   Persistence of Uropathogenic Escherichia coli in the Face of Multiple Antibiotics [J].
Blango, Matthew G. ;
Mulvey, Matthew A. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (05) :1855-1863
[7]   Gallium in cancer treatment [J].
Collery, P ;
Keppler, B ;
Madoulet, C ;
Desoize, B .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 42 (03) :283-296
[8]   Gallium Maltolate Treatment Eradicates Pseudomonas aeruginosa Infection in Thermally Injured Mice [J].
DeLeon, Katrina ;
Balldin, Fredrik ;
Watters, Chase ;
Hamood, Abdul ;
Griswold, John ;
Sreedharan, Sunil ;
Rumbaugh, Kendra P. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (04) :1331-1337
[9]   EXCHANGE OF IRON BY GALLIUM IN SIDEROPHORES [J].
EMERY, T .
BIOCHEMISTRY, 1986, 25 (16) :4629-4633
[10]   Virulence factors of uropathogenic Escherichia coli [J].
Emody, L ;
Kerényi, M ;
Nagy, G .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 22 :S29-S33